Flowers Foods, Inc. (NYSE:FLO). Last Market Price: 20.51, Change: +0.09, % Change: (0.44%). Shares trade in the range of 20.14 – 20.71 dollars. It has a market capitalization of 2.80B dollars, making it a Mid Cap Stock and has 136.42M outstanding shares. The company has a beta of 0.18, indicating, the stock to be less volatile than the market. As per the most recent quarterly report, the net income per share (EPS) is 0.96; P/E of 21.34 indicating, the stock to be overvalued or expected increase in company earnings. It operates in Consumer/Non-Cyclical sector and belongs to Food Processing industry. Percentage shares held by institutional investors is 67%. The company has a 52 week Price range (low – high) of $ 15.95 – 23.13. Average volumes of shares traded daily are 663,937. Volume traded in the last session was at 307,554, 0.46 times the average volume.
- Reports Q3 (Sep)
- EPS of $0.23, in-line with the estimates
- Revenues rose 13.0% year on year to $675.4 million
- Company reaffirms guidance for FY11, sees FY11 revenues of +7-11% Year on Year to ~$2.75-2.86 billion
- Company States: With three quarters completed, we anticipate ending 2011 with sales growth well within our current guidance of 7-11%, including acquisitions. In regard to earnings, we forecasted flat to up 5% for 2011, excluding one-time costs. With fourth quarter input costs being the toughest comparison year-over-year and continued volume pressure in our warehouse segment, we now anticipate earnings for the year will be on the lower end of our earnings guidance range. Looking ahead to 2012, we expect to achieve sales growth in line with our long-term growth target of 5% to 10%.
For Q3 (Jul ’11), It had a Net profit margin of 4.39%, an Operating margin of 6.71%. Other Key stats and ratios are : Return on average assets of 8.38%, Return on average equity of 15.36%. The organization has an employee strength of 8,800
Consensus Recommendation is a Outperform.
Estimate for sales for the Quarter Ending Dec-11 show a mean of 660.61 million dollars, an estimate high of 675.00 million dollars and an estimate low of 647.70 million dollars. A year ago the figures stood at 619.37 million dollars.
Estimate for sales for the Quarter Ending Mar-12 show a mean of 900.47 million dollars, an estimate high of 906.60 million dollars and an estimate low of 888.60 million dollars.
Estimate for EPS for the Quarter Ending Dec-11 show a mean of 0.25 dollars, an estimate high of 0.35 dollars and an estimate low of 0.21 dollars. A year ago the figures stood at 0.26 dollars.
Estimate for EPS for the Quarter Ending Mar-12 show a mean of 0.32 dollars, an estimate high of 0.35 dollars and an estimate low of 0.29 dollars.
Sales for Quarter Ending Jun-11 was estimated at 637.35 million dollars, however the actual sales figure stood at 642.60 million dollars, 5.25 million dollars more than estimates.
Sales for Quarter Ending Mar-11 was estimated at 820.19 million dollars, however the actual sales figure stood at 801.83 million dollars, 18.36 million dollars less than estimates.
 |
Post Written By: Ed Liston
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing in his yacht. |